Sustainable Growth Labiana Health recently earned recognition for sustainable growth on the BME Growth market and is actively highlighted as a success story, signaling credibility and visibility with investors and potential partners.

Diversified Revenue With revenue growth across human and animal health and a broad international presence in over 150 markets, Labiana offers multi-segment collaboration opportunities in contract manufacturing, packaging, and development services.

Strong Manufacturing EU-GMP certified production with tablet manufacturing capacity and advanced coating and packaging lines positions Labiana as a reliable partner for large-scale, regulated pharmaceutical supply needs.

Strategic Partnerships A history of serving multinational clients and integrated drug development support from concept to commercialization presents opportunities for co-development, out‑sourcing, and through‑chain manufacturing services.

Public Market Momentum IPO history and ongoing investor spotlight on growth and profitability suggest potential for partnerships tied to expansion, capacity scaling, and strategic investments in new manufacturing capacities.